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Burkholderia cenocepacia is an opportunistic respiratory pathogen of individuals with cys-
tic ﬁbrosis (CF). Some strains of B. cenocepacia are highly transmissible and resistant to
almost all antibiotics. Approximately one-third of B. cenocepacia infected CF patients go
on to develop fatal “cepacia syndrome.” During the last two decades, substantial progress
has been made with regards to evasion of host innate defense mechanisms by B. ceno-
cepacia. Almost all strains of B. cenocepacia have the capacity to survive and replicate
intracellularly in both airway epithelial cells and macrophages, which are primary sentinels
of the lung and play a pivotal role in clearance of infecting bacteria.Those strains of B. ceno-
cepacia, which express both cable pili and the associated 22 kDa adhesin are also capable
of transmigrating across airway epithelium and persist in mouse models of infection. In
this review, we will discuss how this type of interaction between B. cenocepacia and host
may lead to persistence of bacteria as well as lung inﬂammation in CF patients.
Keywords: cystic fibrosis, innate immunity, inflammation, bacterial pathogenesis, lung infection, cable pili, airway
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The two powerful host defense mechanisms against infecting bac-
teria are innate and adaptive immune systems. The innate immune
system provides immediate protection against intruding bacte-
ria by triggering appropriate host responses that control bacterial
proliferation, dissemination, and elimination. On the other hand,
the adaptive immune system is responsible for elimination of
bacteria at later phases of infection and in the generation of an
immunological memory. A variety of cell types including mucosal
epithelial cells, macrophages, neutrophils, dendritic cells, natural
killer cells, and eosinophils contribute to the innate immune sys-
tem. Since airway epithelium lining the respiratory tract is the ﬁrst
point of contact for inhaled bacterial pathogens, it has evolved
to eliminate pathogens efﬁciently by more than one mechanism
(Diamond et al., 2000;Bals andHiemstra,2004;Mayer andDalpke,
2007; Vareille et al., 2011). These include mucociliary appara-
tus which traps and sweeps the intruding bacteria away from the
lungs (Knowles and Boucher, 2002), potent antimicrobial agents
that kill invading bacterial pathogens (Bals et al., 1998; Hiem-
stra, 2001), junctional complexes between the airway epithelial
cells which prevent bacterial pathogens from gaining access to the
submucosal compartment (Pohl et al., 2009); and pattern recog-
nitionmolecules that stimulate pro-inﬂammatory cytokines upon
recognition of bacteria or bacterial products leading to recruit-
ment and activation of innate immune cells and to the induction
of expression of co-stimulatory molecules on the antigen present-
ing cells (Parker and Prince, 2011). The latter response activates
the adaptive immune system (Medzhitov and Janeway, 1997). Bac-
terial pathogens which escape from epithelial defenses are taken
up by the recruited professional phagocytes and killed. Despite
these multiple layers of host defense, some bacterial pathogens
cause persistent infection suggesting that they have evolved to
evade or subvert host defenses. Opportunistic pathogens, such as,
Pseudomonas aeruginosa and themembers of Burkholderia cepacia
complex can cause both acute and chronic infections preferentially
in cystic ﬁbrosis (CF) patients because, they are thought to have a
defective innate immune system (Chmiel andDavis, 2003; Jacquot
et al., 2008). In this review, we will discuss how Burkholderia ceno-
cepacia, amember of B. cepacia complex evades the innate immune
system and cause persistent respiratory infections in CF patients.
BURKHOLDERIA CENOCEPACIA INFECTION IN INDIVIDUALS
WITH CYSTIC FIBROSIS
Although most members of B. cepacia complex have been isolated
from the lungs of CF patients, B. cenocepacia is one of the most
commonly isolated species inNorthAmerica and Europe (Mahen-
thiralingam et al., 2001; Lipuma, 2005; Drevinek and Mahenthi-
ralingam, 2010). In addition, certain strains of B. cenocepacia are
associated with heightened transmissibility (Govan et al., 1993;
Sun et al., 1995; Pitt et al., 1996; Clode et al., 2000; Woods et al.,
2004), poor clinical outcome, and increased risk of developing
fatal “cepacia syndrome” (Frangolias et al., 1999; Ledson et al.,
2002; Courtney et al., 2004; Jones et al., 2004). B. cenocepacia
is also associated with bacteremia in non-CF adult critically ill-
patients (Siddiqui et al., 2001; Woods et al., 2004; Bressler et al.,
2007). These observations suggest a tropism of this organism to
chronically injured lungs.
By using genetic analysis based on recA gene sequencing, B.
cenocepacia was further divided into four phylogenetic lineages
IIIA to IIID, but most of the CF isolates belong to IIIA and IIIB
(Mahenthiralingam et al., 2000; Vandamme et al., 2003). In the
United States, PHDC and Midwest clones are dominant epidemic
lineages and belong to B. cenocepacia IIIB (Chen et al., 2001;
Coenye and Lipuma, 2003). Strains from the PHDC lineage are
also found in Europe (Coenye et al., 2004). In contrast, ET12
(one of the clonal lineages of B. cenocepacia IIIA) is dominant
in Canada, UK, and other European countries and was responsi-
ble formost of the“cepacia syndrome”-related deaths documented
in Canada and UK during the early 1980s (Isles et al., 1984; Govan
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et al., 1996; Speert et al., 2002). Based on epidemiological stud-
ies, isolates belonging to the ET12 lineage are considered to be
highly transmissible and virulent. As a result, most of the stud-
ies are focused on understanding the mechanisms by which these
organisms evade host innate defense mechanisms.
INVASION OF AIRWAY EPITHELIUM BY B. CENOCEPACIA
The main components of mucus that overlays airway epithelium
are high molecular weight glycoproteins called mucins. These
mucin molecules cross link with each other to provide a struc-
tural framework for the mucus barrier (Rose et al., 2001). Under
normal conditions, binding of bacteria to airway mucins is gen-
erally considered beneﬁcial for the host, as the bacteria bound to
mucins are subsequently cleared by mucociliary action. In addi-
tion, surface mucus also contains antimicrobial products which
kill trapped bacteria (Singh et al., 1998; Moskwa et al., 2007).
In contrast, under the conditions of impaired mucociliary clear-
ance and reduced activity or absence of antimicrobial products
as observed in CF patients (Singh et al., 1998; Boucher, 2004,
2007; Conner et al., 2007; Moskwa et al., 2007), bacteria bound
to mucin may persist in the airway lumen and gain access to
airway epithelial cells. Previously, we have demonstrated that
the majority of clinical isolates collected during the B. cepacia
epidemic in Toronto CF center bind to mucin and this bind-
ing was mediated by a 22-kDa adhesin protein associated with
cable pili (Sajjan and Forstner, 1992; Sajjan et al., 1992). All the
mucin binding isolates belong to the ET12 lineage and were found
to express both cable pili and the 22-kDa adhesin (Sajjan and
Forstner, Unpublished observations). The isolates which showed
the highest binding to mucin were recovered from patients who
ultimately died due to fatal “cepacia syndrome,” suggesting that
cable pili and the associated 22 kDa adhesin may be necessary
for persistent bacterial infections leading to “cepacia syndrome”
(Sajjan et al., 1992). Consistent with this notion, we found that
cable and adhesin positive B. cenocepacia isolates preferentially
persist in the apical mucus layer as microcolonies (bioﬁlm) in
CF airway epithelial cells differentiated into a mucociliary phe-
notype (Sajjan et al., 2004; Figure 1). We also found individual
bacteria deeper in the epithelial cell layer 24 h after infection,
indicating that some bacteria escape from the mucus layer and
invade the underlying epithelial cells. In contrast, normal air-
way epithelial cells differentiated into a mucociliary phenotype
trapped the added B. cenocepacia in the apical mucus and pre-
vented bacteria from invading the cells. Compared to normal,
CF cell cultures also showed 100-fold more bacteria possibly
due to the inefﬁcient killing of bacteria by airway epithelial
cell-derived antimicrobials. CF airway epithelial cells have been
demonstrated to be defective in producing antimicrobial prod-
ucts (Singh et al., 1998; Conner et al., 2007; Moskwa et al.,
2007). However, B. cenocepacia which is inherently resistant to
many antibiotics is also resistant to killing by a cationic pep-
tide, β-defensin (Baird et al., 1999). β-defensin is expressed by
both airway epithelial cells and inﬂammatory cells and there-
fore present abundantly in airway lumen (Singh et al., 1998).
This may partly explain the persistence of bacteria (although
fewer in numbers) in the apical mucus layer of normal airway
epithelial cell cultures. However, Schwab et al. (2002) demon-
strated that cable and adhesin positive B. cenocepacia also persist
FIGURE 1 | Cable and adhesin positive B. cenocepacia invade
well-differentiated CF, but not normal airway epithelial cells. (A,B) Cross
sections of B. cenocepacia-infected normal and CF airway epithelial cell
cultures stained with hemotoxylin and eosin. (C,D) Localization of
bacteria in normal and CF airway epithelial cells infected with
B. cenocepacia.
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in the apical mucus in the form of microcolonies and also invade
mucociliary-differentiatednormal airway epithelial cells leading to
extensive cell damage. This may be due to higher infection doses
used in this study, which could overwhelm the innate immune
defenses of airway epithelial cells in culture.
Removal of apical mucus prior to infection with B. cenocepacia
increased bacterial invasion of airway epithelium in both normal
and CF airway epithelial cell cultures (Sajjan et al., 2004). How-
ever, while invaded bacteria in normal airway epithelial cells were
contained in endocytic vesicles and killed, bacteria in CF epithelial
cells appeared to be intact and also caused extensive damage. Con-
sistent with these observations, cable and adhesin positive bacteria
were also found to be less destructive than other strains of B. ceno-
cepacia and Burkholderia multivorans in normal polarized cells
(Duff et al., 2006). B. cenocepacia strains other than ET12 also
transmigrate across normal polarized airway epithelial cell cul-
tures by causing dissociation of occludin from the tight junction
complex (Kim et al., 2005). Similarly, B. multivorans and non-CF
isolates belonging to the generaBurkholderia stabilis andB. cepacia
also invaded polarized normal airway epithelial cells by paracyto-
sis and lead to loss of zona occludens and occludin from the tight
junction complex (Duff et al., 2006).
Cable and adhesin positive B. cenocepacia also invade
squamous-differentiated normal airway epithelial cells efﬁciently
(Sajjan et al., 2002; Urban et al., 2005). Squamous epithelium rep-
resents respiratory epithelium undergoing squamous metaplasia
and/or repair following epithelial injury, and express cytokeratin
13 (Leube and Rustad, 1991; Roger et al., 1999). Mutants defec-
tive in expression of cable pili and the 22-kDa adhesin do not
bind to isolated cytokeratin 13. These mutants are also attenu-
ated in their capacity to transmigrate across squamous epithelium
(Urban et al., 2005), suggesting a role for cable pili and the 22-kDa
adhesin in this process. It is not uncommon for pathogenic bac-
teria to utilize cytokeratins as receptors. For instance, undeﬁned
type of cytokeratins on injured corneal epithelial cells were iden-
tiﬁed as receptors for pili isolated from P. aeruginosa PAK strain
(Wu et al., 1996). Interaction with cytokeratin 10 was proposed
to contribute to colonization of nasal mucosa by Staphylococ-
cus aureus (O’brien et al., 2002). Since CF airway epithelium
undergoes repeated injury and repair, it may express increased
cytokeratin 13. Therefore, it is possible that cable and the 22-kDa
adhesin positive B. cenocepacia which has the capacity to bind to
cytokeratin 13 may readily bind and invade CF airway epithelium
expressing cytokeratin 13.
Neither CF nor normal airway epithelial cells which are dif-
ferentiated into the mucociliary phenotype express cytokeratin
13. Yet, cable and adhesin positive B. cenocepacia invade CF air-
way epithelial cells and to some extent normal epithelial cells
(Sajjan et al., 2004). Other strains of B. cenocepacia and B. mul-
tivorans also invade mucociliary airway epithelial cells (Schwab
et al., 2002). B. cenocepacia other than ET12 strain and B. mul-
tivorans were also shown to traverse polarized airway epithelial
cell lines by dissociating zona occludens-1 and/or occludin from
the tight junction complex (Kim et al., 2005; Duff et al., 2006).
Such observations suggest interaction of these organisms with
cellular receptors other than cytokeratin 13 that facilitate entry
of bacteria into cells. Consistent with this notion, both cable
piliated and non-cable piliatedB. cenocepacia were shown to inter-
act with glycolipid receptors, primarily with galactose-containing
globotriaosylceramides Gb2 and Gb3 and moderately with asialo
GM1 and asialoGM2 (Sylvester et al., 1996). Similar to these ﬁnd-
ings, uncharacterized members of the B. cepacia complex were
shown to bind to puriﬁed asialo GM1 and asialo GM2 (Krivan
et al., 1988). However, the contribution of bacterial interaction
with glycolipid receptors in invasion of epithelial cells or other
host responses was not investigated in these earlier studies. Inter-
estingly, adherence to unspeciﬁed glycosphingolipids was demon-
strated to promote invasion of epithelial cells by B. multivorans
and cable piliated B. cenocepacia (Mullen et al., 2010). Several
investigators have reported that P. aeruginosa interact with asialo
GM1 (Imundo et al., 1995; De Bentzmann et al., 1996; Davies
et al., 1999). Such interaction was shown to activate cytotoxicity
and internalization of bacteria by epithelial cells (Feldman et al.,
1998; Comolli et al., 1999).
In addition, ﬂagella also appear to be required for optimal inva-
sion of A549 (alveolar type II epithelial) cells by B. cenocepacia as
non-motile mutants of B. cenocepacia strain (belonging to the
ET12 lineage) with a disruption in genes encoding ﬂagellar genes
(ﬂiG or ﬂiI) were attenuated in invading A549 cells (Tomich et al.,
2002). Flagella of P. aeruginosa has been shown to interact with
asialo GM1 (Feldman et al., 1998; Adamo et al., 2004) and this
interaction increased invasion of epithelial cells by this organ-
ism (Feldman et al., 1998). Expression of asialo GM1 is increased
on the apical surface of CF airway epithelial cells (Muir et al.,
2004). Therefore, it is likely that binding of B. cenocepacia with
asialo GM1 mediated by ﬂagella may promote invasion of airway
epithelial cells by this organism.
BURKHOLDERIA CENOCEPACIA STIMULATES
DISPROPORTIONATE PRO-INFLAMMATORY CYTOKINE
RESPONSE BY SUBVERTING INNATE IMMUNE RECEPTORS
Interaction of bacteria or bacterial products with innate immune
receptors such as toll-like receptors (TLR) is expected to be ben-
eﬁcial for the host, because it elicits pro-inﬂammatory cytokine
responses that are required for recruitment of neutrophils.
However, abnormal stimulation of TLR may lead to excessive
chemokine response and increased recruitment of neutrophils.
Similarly, interaction of bacteria with cytokine receptors may acti-
vate autocrine pathway resulting in disproportionately increased
production of chemokines and recruitment of neutrophils. This
combined with impaired clearance of recruited neutrophils by
efferocytosis as observed in CF lungs may lead to lung injury
(Vandivier et al., 2006, 2009).
Bacterial products such as lipopolysaccharides (LPS), ﬂagella,
pili, and lipopeptides are recognized by different TLRs in both
lung epithelial cells and inﬂammatory cells and stimulate produc-
tion of pro-inﬂammatory cytokines. LPS isolated from B. cepacia
complex was found to elicit ninefold higher pro-inﬂammatory
cytokines than LPS from P. aeruginosa in leukocytes (Shaw et al.,
1995; Zughaier et al., 1999). Following this, De Soyza et al. (2004)
examined whole bacterial cell lysates of representative isolates
belonging to all the members of B. cepacia complex to stimu-
late pro-inﬂammatory cytokines in a human monocytic cell line,
U937. They found that in general, lysates of B. cenocepacia and
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B. multivorans species are signiﬁcantly more potent stimulators
of pro-inﬂammatory cytokines than the other species. Based on
the structural analysis of lipid A moiety from a limited number
of strains, the difference between pro-inﬂammatory activity of
LPS was proposed to be due to differences in acylation of lipid
A (De Soyza et al., 2004). The strains that lack primary acylation
chain in lipid A stimulated the least pro-inﬂammatory responses
in macrophages. Later, highly puriﬁed LPS from different isolates
belonging to B. cenocepacia ET12 lineage or B. multivorans was
demonstrated to elicit varying levels of TNF-α in a Mono Mac
6 (human monocytic cell line; Bamford et al., 2007). This was
dependent on the interaction of puriﬁed LPS with TLR4 and the
activation of MyD88-dependent signaling pathway.
Recently, it was demonstrated that O antigen of LPS from
B. cenocepacia also stimulate IL-1β in murine macrophages and
this was dependent on both TLR4 and caspase-1 (Kotrange et al.,
2011). Knockdown of TLR4 or caspase-1 abrogated B. cenocepa-
cia-induced IL-1β. Knockdown of MyD88, an adaptor protein
downstream of TLR4 also completely inhibited B. cenocepacia-
induced IL-1β, indicating the requirement of MyD88-dependent
TLR4 signaling in this process. Caspase-1 is normally activated
by NOD-like receptors, which are a family of intracellular pattern
recognition receptors and sensemicrobial signatures in the cytosol.
So far, 22NLR’s have been identiﬁed in humans.NOD1 andNOD2
are the most widely studied NLRs, which detect components
from both gram positive and Gram negative bacteria and acti-
vate inﬂammasome leading to caspase-1 expression (Chamaillard
et al., 2003;Girardin et al., 2003a,b). However activation of inﬂam-
masome also requires a second signal that is usually elicited by one
of the TLRs and based on the observations from Kotrange et al.
(2011) TLR4 appears to be involved in B. cenocepacia O antigen-
stimulated inﬂammasome activation and caspase-1 expression.
The identity of NLR that sense B. cenocepacia O antigen is yet
to be determined.
Interestingly, LPS from B. cenocepacia isolates K56-2 or BC7
was found to be less efﬁcient in stimulating TNF-α in mono-
cytes than other B. cenocepacia isolates (De Soyza et al., 2004).
Yet, CFTR knockout mice infected with either K56-2 or BC7 show
more severe lung inﬂammation than mice infected with isolates
from other species (Chattoraj et al., 2010). These two B. ceno-
cepacia isolates also elicited more IL-8 expression in primary CF
airway epithelial cells than the other B. cenocepacia isolates exam-
ined (Sajjan et al., 2004) suggesting that in addition to LPS, other
pro-inﬂammatory factors may also contribute to B. cenocepa-
cia-induced excessive stimulation of pro-inﬂammatory cytokines,
particularly in CF lungs. Consistent with this notion, binding of
P. aeruginosa ﬂagella to asialo GM1 was shown to cooperate with
TLR5 in stimulating IL-8 production and to induce nucleotide sig-
naling leading ERK1/2 activation in airway epithelial cells (Adamo
et al., 2004;Mcnamara et al., 2006). Since asialo GM1 expression is
increased in CF airway epithelial cells it is possible that such coop-
erative interactions between asialo GM1 andTLR5 are operative in
these cells. Accordingly,B. cenocepacia-induced pro-inﬂammatory
responses in airway epithelial cells was shown to involve TLR5, but
not TLR2 or TLR4 (De et al., 2008).
Flagella from B. cenocepacia K56-2 was demonstrated to elicit
chemokine and cytokine responses both in vitro and in vivo
by interacting with TLR5 (Urban et al., 2004). However, it was
not demonstrated whether this interaction stimulates higher
chemokine responses in CF than in normal cells. Interestingly, we
found that some strains of B. cenocepacia including BC7 binds to
TNF receptor 1 (TNFR1) and activates TNFR signaling leading to
IL-8 production in CF airway epithelial cells (Sajjan et al., 2008b).
Further,we observed co-localization of B. cenocepacia withTNFR1
in the airway epithelium of a CF patient infected with cable and
the 22-kDa adhesin positive B. cenocepacia. Although activation
of TNFR1 by TNF-α plays a critical role in host defense, patho-
genic bacteria that have the capacity to bind to this receptor can
subvert the pathway to heighten the host inﬂammatory responses.
As observed for B. cenocepacia, S. aureus has also been shown to
bind to TNFR1 in airway epithelial cells and induce a TNFR1-
related signaling pathway leading to IL-8 expression (Gomez et al.,
2004). Protein A, a major surface protein present in almost all
strains of S. aureus has been identiﬁed as a bacterial ligand. In a
murine model of lung infection, the interaction of protein A with
TNFR1 results in recruitment of neutrophils to airways, leading
to severe inﬂammation. However whether interaction of B. ceno-
cepacia with TNFR1 increases lung inﬂammation in vivo is yet to
be examined. B. cenocepacia ligand that interacts with TNFRI is
also not known.
BURKHOLDERIA CENOCEPACIA SUBVERTS THE ENDOCYTIC
PATHWAY
Various studies have shown that B. cenocepacia has the capacity to
survive intracellularly. This trait may contribute to the organism’s
ability to persist and evade host defenses in vivo during chronic
infection. Burns et al. (1996) were the ﬁrst to demonstrate that
a strain of B. cepacia complex isolated from a CF patient invade
airway epithelial cells in vitro and the bacteria-positive vesicles
were found not to fuse with lysosomes. Immunolocalization stud-
ies using lung sections from CF patients who were chronically
infected with strains of the B. cepacia complex indicated presence
of B. cepacia frequently in the intercellular junctions of airway
epithelium, inside the airway epithelial cells, andmacrophages, but
rarely in the airway lumen (Sajjan et al., 2001a). These ﬁndings
conﬁrmed that the strains of the B. cepacia complex are capa-
ble of surviving intracellularly in both airway epithelial cells and
macrophages during chronic infection. B. cenocepacia elaborated
factors such as ﬂagella and lipase appear to promote bacterial inva-
sion of lung epithelial cells, but not survival or replication (Tomich
et al., 2002; Mullen et al., 2010). Interestingly, exogenously added
IL-8 also increased invasion of A549 cells by B. cenocepacia com-
plex in a dose dependentmanner. Based on this observation, it was
postulated that strains that elicit more IL-8 may invade cells with
higher propensity (Kaza et al., 2011).
Intracellular survival and replication of B. cenocepacia appears
to require type IV secretion system (T4SS; Sajjan et al., 2006,
2008a), similar to that observed for L. pneumophila and Bru-
cella (reviewed in De Jong et al., 2010; Hubber and Roy, 2010).
Analysis of the completely sequenced genome of B. cenocepacia
belonging to the ET12 lineage Engledow et al. (2004) identi-
ﬁed two T4SSs. One of these is encoded on chromosome 2 and
bears homology to the VirB/D4 T4SS of Agrobacterium tumefa-
ciens (Christie et al., 2005). The second, Ptw T4SS, is encoded by
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a 92-kb resident megaplasmid and is a chimeric system composed
ofVirB/D4 and F-speciﬁc subunits (Engledow et al., 2004; Christie
et al., 2005). Insertional inactivation of ptwD4 of the Ptw system
attenuated intracellular survival and replication of B. cenocepacia
strain K56-2 (Sajjan et al., 2008a). PtwD4 is homologous to cou-
pling proteins of otherT4SSs and involved in effector translocation
(Engledow et al., 2004). Both wild-type and ptwD4mutant invade
CF airway epithelial cells and monocyte derived macrophages at
a similar level. However, 24 h post infection, higher number of
wild-type than theptwD4 mutant was recovered from both CF
airway epithelial cells and monocyte derived macrophages. The
observed difference between the wild-type and ptwD4 mutant
was found to be due to altered intracellular trafﬁcking. Immedi-
ately after entry into airway epithelial cells or macrophages, both
wild-type and the ptwD4mutant co-localized to early endosomes.
However, while most of the wild-type bacteria containing vac-
uoles failed to acquire cathepsin D (a lysosomal marker), twice as
many ptwD4 mutant containing vacuoles acquired cathepsin D,
suggesting that unlike wild-type bacteria containing vacuoles, a
proportion of ptwD4 mutant containing vacuoles fuse normally
with lysosomes and the bacteria are subsequently killed by a typical
endosomal pathway. Mutant bacteria that escape the typical endo-
somal pathway were targeted to autophagosomes which eventually
fused with lysosome and bacteria in the autophagolysosome were
killed. In contrast, amajority of vacuoles containingwild-typebac-
teria excluded early endosomal marker and acquired markers of
autophagosomes suggesting presence of bacteria in the autophago-
somes. However, unlike ptwD4 mutant containing autophago-
somes,wild-type bacteria containing autophagosomes didnot fuse
with the lysosomes. As a result, wild-type bacteria that persist in
the autophagosomes appear to escape from the autophagosomes
and replicate in endoplasmic reticulum (Figure 2). These obser-
vations demonstrate how B. cenocepacia can subvert the normal
endosomal pathway to its beneﬁt.
To understand the mechanism by which B. cenocepacia prevent
fusion of endosomes with lysosome, Huynh et al. (2010) per-
formed elegant studies using a synchronized phagocytosis assay
and ﬂuorescence recovery after photo-bleaching techniques. Sim-
ilar to above observations, these authors also found defective
fusion of B. cenocepacia containing vacuoles with the lysosomes in
macrophages. Rab7 plays an important role in directing the fusion
of phagosomes not only with late endosomes, but also with the
lysosomes. Therefore using GFP–Rab7 transfected macrophages,
a more sensitive method for detecting Rab7 recruitment to endo-
somes than the conventional immunolocalization, the authors
showed that Rab7 was recruited to majority of B. cenocepacia
containing vacuoles (Huynh et al., 2010). Despite this, B. ceno-
cepacia containing vacuoles failed to fuse with the lysosomes. This
prompted the authors to examine the cycling of recruited Rab7
between the guanosine triphosphate (GTP) to guanosine diphos-
phate (GDP)-bound forms of Rab7, as this is required for efﬁcient
fusion of bacteria containing vacuoleswith lysosomes (Vieira et al.,
2003). Fluorescence recovery after photo-bleaching of GFP–Rab7
was used to examine the cycling of GTP to GDP-bound form
of Rab7 in B. cenocepacia infected cells. In the steady state, the
rate of ﬂuorescence recovery after bleaching of the entire bacteria
containing vacuole is dictated by exchange of the photo-bleached
membrane bound Rab7 with ﬂuorescent cytosolic (unbleached)
Rab7, a process that is determined in part by the rate of conver-
sion of Rab7–GDP to the GTP-bound form (Vieira et al., 2003).
The rate of ﬂuorescence recovery in vacuoles containing live B.
cenocepacia was remarkably slower and less compared to those
FIGURE 2 | Burkholderia cenocepacia PtwT4SS is required for subversion of endosomal pathway in host innate immune cells.
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containing dead bacteria suggesting that these organismsmay pre-
vent the fusion of endosomes by retaining inactive GDP-bound
form of Rab7.
In addition to preventing fusion of endosomes with lysosomes,
B. cenocepacia also delays acidiﬁcation of vacuoles inmacrophages
(Lamothe et al., 2007; Saldias and Valvano, 2009). The bacte-
rial factor which plays a role in this process is thought to be
regulated by alternative sigma factor RpoE, which controls the
expressionof genes required for extracellular stress response (Flan-
nagan andValvano, 2008). Inactivation of rpoE reduced the ability
of intracellular B. cenocepacia to prevent acidiﬁcation of bacteria
containing vacuoles. As a result bacteria were targeted to the classi-
cal endocytic pathway. However the precise RpoE controlled gene
product that is responsible for preventing acidiﬁcation of bacteria
containing vacuole is yet to be identiﬁed.
BURKHOLDERIA CENOCEPACIA IS RESISTANT TO KILLING
BY HOST-DERIVED ANTIMICROBIALS
Another mechanism by which B. cenocepacia evade host defenses
is via inactivating and/or preventing expression of host elaborated
antimicrobials. The LPS of B. cenocepacia and other members
of Burkholderia species is unique in that it contains 4-amino-
4-deoxy-l-arabinose (Ara4N) residues in the lipid A and inner
core oligosaccharide (Vinion-Dubiel and Goldberg, 2003). Ara4N
moieties are positively charged, and therefore they reduce the
net charge on the external membrane. This renders bacteria
resistant to cationic antimicrobial peptides, including defensins
which are enriched in the respiratory tract (Albrecht et al., 2002;
Vinion-Dubiel and Goldberg, 2003; Loutet et al., 2006).
B. cenocepacia secretes zinc metalloproteases (Zmp)A and
ZmpB (Kooi et al., 2005, 2006) in addition to other proteases.
ZmpA is positively regulated by the CepR quorum-sensing sys-
tem, whereas ZmpB is positively regulated by both CepIR and
CcilR quorum-sensing systems (Gingues et al., 2005; Kooi et al.,
2006). Both ZmpA and ZmpB have broad-spectrum proteolytic
activity and degrade matrix proteins, antiproteinases, and α2-
macroglobulin. ZmpA also degrades interferon-γ, and ZmpB
degrades transferrin and immunoglobulins (Kooi et al., 2005,
2006). These proteases were also found to degrade antimicro-
bial peptides. Both proteases cleave elaﬁn and secretory leukocyte
inhibitors.While ZmpA degrades cathelicidin LL37, ZmpB cleaves
β-defensin (Kooi and Sokol, 2009). Mutants of CepIR quorum-
sensing system are less invasive and cause less lung inﬂammation
than their wild-type counterparts in CF mice (Sokol et al., 2003),
suggesting that ZmpA and ZmpB may contribute to bacterial
evasion of antimicrobial defenses in vivo (Sokol et al., 2003).
B. cenocepacia is also resistant to killing by phagocytes. Some
strains of B. cenocepacia produce large amounts of exopolysac-
charides (EPS), which makes bacteria mucoid (Cerantola et al.,
2000). Some of the CF clinical isolates were found to express
EPS when cultured on solid media (Herasimenka et al., 2007)
and also in a mouse model of infection (Conway et al., 2004). B.
cenocepacia EPS differ chemically from P. aeruginosa exopolysac-
charide alginate (Cerantola et al., 1996; Sist et al., 2003; Conway
et al., 2004), but can still inactivate cathelicidin peptides similar
to alginate (Foschiatti et al., 2009). The EPS from B. cenocepacia
also inhibits neutrophil chemotaxis and scavenges reactive oxygen
species in vitro (Bylund et al., 2006). Subsequently B. cenocepacia
was also demonstrated to delay the assembly of NADPH oxidase
enzyme complex in the phagosomes (Keith et al., 2009). NADPH
oxidase is the major source of superoxide, a precursor of potent
microbicidal reactive oxygen species such as hydrogen peroxide,
hydroxyl radical, and hypochlorous acid (Fang, 2004).
SUMMARY
The picture emerging from these studies is that B. cenocepa-
cia, an important opportunistic pathogen in CF patients can
evade the innate immune system by multiple mechanisms. This
results in either chronic bacterial colonization, or acute infection,
which is associated with severe lung inﬂammation and some-
times development of necrotizing pneumonia and death. The
majority of B. cenocepacia strains express factors that protect bac-
teria from host-derived antimicrobial factors, thus providing a
mechanism for evading antimicrobial host defenses. Some strains
of B. cenocepacia, particularly those isolated from patients who
succumbed to fatal “cepacia syndrome” bind to multiple host
receptors including TNFR1 and elicit heightened IL-8 response
(Sajjan et al., 2008b). This may result in excessive recruitment
of neutrophils ultimately leading to extensive lung damage in
CF patients, as mechanisms for removal of apoptotic neutrophils
is defective in these patients (Vandivier et al., 2009). Consistent
with this idea, strains that are capable of binding to TNFR1
caused severe inﬂammation in lungs of CF mice (Sajjan et al.,
2001b; Chattoraj et al., 2010). However, further studies using
TNFR1 knockout mice are required to establish direct contri-
bution of B. cenocepacia binding to TNFR1 in development of
severe lung disease. In addition, these isolates also express the
cable pilus and the associated 22 kDa adhesin and each of which
were found to be required for eliciting maximal IL-8 in vitro and
lung inﬂammation in vivo (Urban et al., 2005; Goldberg et al.,
2011).
SomeB. cenocepacia strains also have the capacity to invade and
reside inside airway epithelial cells or macrophages by subverting
the normal endocytic pathway (Sajjan et al., 2006; Lamothe et al.,
2007; Huynh et al., 2010). This may provide a suitable niche for
the bacteria to persist chronically in the lungs of CF patients with-
out being recognized by innate immune cells. Consistent with this
notion, lung sections frompatientswhowere chronically colonized
with B. cenocepacia showed bacteria inside the airway epithelial
cells andmacrophages (Sajjan et al., 2001a). Although not much is
known about the bacterial factors that subvert the endocytic path-
way, Ptw T4SS appears to contribute to this process (Sajjan et al.,
2008a). Investigations on identiﬁcation of Ptw T4SS effectors and
how they interact with the components of endocytic pathway will
substantially enhance our understanding of the mechanisms by
which these organisms subvert the endocytic pathway.
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